• Department of Cardiac Surgery, Guangdong Provincial People's Hospital, Guangdong Provincial Academy of Medical Sciences, Guangdong Provincial Institute of Cardiovascular Diseases, Guangzhou, 510000, P.R.China;
GUO Huiming, Email: guohuiming@vip.tom.com
Export PDF Favorites Scan Get Citation

Objective To investigate the perioperative results and safety of minimally invasive direct coronary artery bypass grafting (MIDCAB) treatment of anterior descending artery disease through a small left thoracic incision assisted by thoracoscopy. Methods The clinical data of 92 patients who received MIDCAB in our hospital from May 2014 to October 2018 were retrospectively analyzed, including 72 (78.26%) males aged 42-78 (61.2±7.48) years, and 20 (21.74%) females aged 30-80 (61.30±12.26) years. The perioperative complications, blood product use, left heart function changes, ventilator use time, ICU stay, hospital stay and other indicators were analyzed. Results Two (2.17%) patients were transferred to thoracotomy, 5 (5.43%) patients received blood products during the operation, 2 (2.17%) were subjected to secondary thoracotomy to stop bleeding, 4 (4.34%) had postoperative hypoxemia and 1 (1.08%) was reintubated. The ventilator use time was 3-227 (22.35±35.39) hours, the ICU stay was 16-777 (78.85±108.62) hours, and the postoperative hospital stay was 2-36 (8.86±6.05) days. One (1.08%) patient died in hospital. Conclusion MIDCAB for anterior descending artery disease has good perioperative results, especially for solitary anterior descending artery disease, which can reduce the use of blood products, and shorten the time of ventilator use after operation, ICU stay and hospital stay.

Citation: ZHANG Zhen, LIU Jian, ZENG Qingshi, XIE Bin, GUO Huiming. Perioperative results of minimally invasive direct coronary artery bypass grafting for left anterior descending artery revascularization. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2021, 28(2): 198-201. doi: 10.7507/1007-4848.202008071 Copy

  • Previous Article

    Analysis of projects in liver transplantation by National Natural Sciences Foundation ofChina from 2010–2019
  • Next Article

    The expression of Hsa-miR-29c in gastric cancer and its clinical significance